NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ('NurExone” or the 'Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system ...
-- Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were ...
Near-term – Closing and funding of the Quazar Investment of $50 million.
The good news is that Amazon has just dropped the 51mm Solar Sapphire model to $849 for Black Friday, down from its regular $1,199 price. That makes it an all-time low that brings the grail of sports ...
Lithuanian-Manufactured Bilateral Cervical Vagus Nerve Stimulator Leads Consumer Wellness Category With 100,000+ Verified ...
Not getting enough sleep does more than make you tired. Here’s how short nights can quietly raise your blood pressure, and ...
Working full-time and having insurance has not insulated Ashaki Sypher's family from teetering on financial collapse. Her daughter, 16, has brain injury, disorders that demand care.
NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...
Pulsetto earned the 2025 Global Recognition Award for adapting medical-grade bilateral vagus nerve stimulation into a consumer wearable.
Nuvation Bio Inc. is rated a Hold due to recent price surge and near-term volatility, awaiting clearer sales data. Learn more ...
Months into ICE raids, Chicago teachers and community members are finding ways to help students cope with trauma inflicted on ...
Learn more about whether Immunocore Holdings plc or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback